Advances in the Management of Spontaneous Intracerebral Hemorrhage

Critical Care Clinics

Volumn 22, Issue 4, 2006, Pages 607-617

  Naval, Neeraj S ^a   Nyquist, Paul A ^a   Carhuapoma, J Ricardo ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; NICARDIPINE; PHENYTOIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STREPTOKINASE; UROKINASE; VITAMIN K GROUP; WARFARIN;

BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD PRESSURE REGULATION; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL TRIAL; CRANIOTOMY; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; INTRACRANIAL HYPERTENSION; MINIMALLY INVASIVE CARDIAC SURGERY; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SEIZURE; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; CRITICAL CARE; HUMANS;

EID: 33846311411     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2006.11.007     Document Type: Review

References (59)

1. Broderick J.P., Adams Jr. H.P., Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30 4 (1999) 905-915
2. Schellinger P.D., Fiebach J.B., Hoffmann K., et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke 34 (2003) 1674-1679
3. Jauch E.C., Lindsell C.J., Adeoye O., et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 37 8 (2006) 2061-2065
4. Flibotte J.J., Hagan N., O'Donnell J., et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63 6 (2004) 1059-1064
5. Lee S.B., Manno E.M., Layton K.F., et al. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 67 7 (2006) 1272-1274
6. Diringer M.N. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 21 10 (1993) 1591-1603
7. Bhardwaj A., and Ulatowski J.A. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 10 2 (2004) 126-131
8. Dereeper E., Berre J., Vandesteene A., et al. Barbiturate coma for intracranial hypertension: clinical observations. J Crit Care 17 1 (2002) 58-62
9. Kang T.M. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 36 9 (2002) 1453-1456
10. Steiner T., Ringleb P., and Hacke W. Treatment options for large hemispheric stroke. Neurology 57 5, Suppl 2 (2001) S61-S68
11. Poungvarin N., Bhoopat W., Viriyavejakul A., et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 316 (1987) 1229-1233
12. Bladin C., Alexandrov A., Bellavance A., et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 57 (2000) 1617-1622
13. Kilpatrick C., Davis S., Tress B., et al. Epileptic seizures after stroke. Arch Neurol 47 (1990) 157-169
14. Vespa P. Continuous EEG monitoring for the detection of seizures in traumatic brain injury, infarction, and intracerebral hemorrhage: "to detect and protect". J Clin Neurophysiol 22 2 (2005) 99-106
15. Vespa P.M., O'Phelan K., Shah M., et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60 9 (2003) 1441-1446
16. Naidech A.M., Kreiter K.T., Janjua N., et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36 3 (2005) 583-587
17. Silverman I.E., Restrepo L., and Mathews G.C. Poststroke Seizures. Arch Neurol 59 2 (2002) 195-201
18. Zhu X.L., Chan M.S., and Poon W.S. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 28 (1997) 1406-1409
19. Brott T., Broderick J., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28 1 (1997) 1-5
20. Davis S.M., Broderick J., Hennerici M., et al. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66 8 (2006) 1175-1181
21. Gebel Jr. J.M., Jauch E.C., Brott T.G., et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 11 (2002) 2636-2641
22. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 8 (2005) 777-785
23. Broderick J.P., Brott T., Tomsick T., et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 78 (1993) 188-191
24. Lapointe M., and Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev (2002) (3):CD003692
25. Qureshi A.I., Tuhrim S., Broderick J.P., et al. Spontaneous intracerebral hemorrhage. N Engl J Med 344 (2001) 1450-1460
26. Broderick J.P., Brott T.G., Duldner J.E., et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24 (1993) 987-993
27. Gebel Jr. J.M., Jauch E.C., Brott T.G., et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2631-2635
28. Azarov I., Huang K.T., Basu S., et al. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem 25 (2005) 39024-39032
29. Auer L.M., Deinsberger W., Niederkorn K., et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 70 (1989) 530-535
30. Marquardt G., Wolff R., and Seifert V. Multiple target aspiration technique for subacute stereotactic aspiration of hematomas within the basal ganglia. Surg Neurol 60 1 (2003) 8-13
31. Tzaan W.C., Lee S.T., and Lui T.N. Combined use of stereotactic aspiration and intracerebral streptokinase infusion in the surgical treatment of hypertensive intracerebral hemorrhage. J Formos Med Assoc 96 12 (1997) 962-967
32. Mendelow A.D., Gregson B.A., Fernandes H.M., et al. STICH Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365 9457 (2005) 387-397
33. Rohde V., Rohde I., Thiex R., et al. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97 4 (2002) 954-962
34. Narayan R.K., Narayan T.M., Katz D.A., et al. Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 62 4 (1985) 580-586
35. Kaufman H.H., Schochet S., Koss W., et al. Efficacy and safety of tissue plasminogen activator. Neurosurgery 20 3 (1987) 403-407
36. Wagner K.R., Xi G., Hua Y., et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg 90 3 (1999) 491-498
37. Teernstra O.P., Evers S.M., Lodder J., et al. Stereotactic treatment of intracerebral hematoma by means of plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 (2003) 968-974
38. Montes J.M., Wong J.H., Fayad P.B., et al. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma: protocol and preliminary experience. Stroke 31 (2000) 834-840
39. Lippitz B.E., Mayfrank L., Spetzger U., et al. Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtpa) after stereotactic aspiration: initial results. Acta Neurochir (Wien) 127 (1994) 157-160
40. Rohde V., Rohde I., Reinges M.H., et al. Frameless stereotactically guided catheter placement and fibrinolytic therapy for spontaneous intracerebral hematomas: technical aspects and initial clinical results. Minim Invasive Neurosurg 43 (2000) 9-17
41. Mohadjer M., Braus D.F., Myers A., et al. CT-stereotactic fibrinolysis of spontaneous intracerebral hematomas. Neurosurg Rev 15 (1992) 105-110
42. Thiex R., Rohde V., Rohde I., et al. Frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral hemorrhage. J Neurol 251 12 (2004) 1443-1450
43. Vespa P., Miller C., McArthur D., et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocritical Care 1 (2004) 268
44. Miller D.W., Barnett G.H., Kormos D.W., et al. Stereotactically guided thrombolysis of deep cerebral hemorrhage: preliminary results. Cleve Clin J Med 60 (1993) 321-324
45. Schaller C., Rohde V., Meyer B., and Hassler W. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery 36 (1995) 328-333
46. Barrett R.J., Hussain R., Coplin W.M., et al. Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage. Neurocrit Care 3 3 (2005) 237-245
47. Naff N.J., Carhuapoma J.R., Williams M.A., et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31 (2000) 841-847
48. Matsumoto K., and Hondo H. CT-guided stereotaxic evacuation of hypertensive intracerebral hematomas. J Neurosurg 61 (1984) 440-448
49. Hondo H., Uno M., Sasaki K., et al. Computed tomography controlled aspiration surgery for hypertensive intracerebral hemorrhage. Experience of more than 400 cases. Stereotact Funct Neurosurg 54-55 (1990) 432-437
50. Hondo H., Matsumoto K., Tomida K., et al. CT-controlled stereotactic aspiration in hypertensive brain hemorrhage. Six-month postoperative outcome. Appl Neurophysiol 50 (1987) 233-236
51. Niizuma H., Otsuki T., Johkura H., et al. CT-guided stereotactic aspiration of intracerebral hematoma-result of a hematoma-lysis method using urokinase. Appl Neurophysiol 48 (1985) 427-430
52. Horimoto C., Yamaga S., Toba T., et al. [Stereotactic evacuation of massive hypertensive intracerebral hemorrhage.]. No Shinkei Geka 21 6 (1993) 509-512 [in Japanese]
53. Amano K., Kawamura H., Tanikawa T., et al. Surgical treatment of hypertensive intracerebral haematoma by CT-guided stereotactic surgery. Acta Neurochir Suppl (Wien) 39 (1987) 41-44
54. Tanikawa T., Amano K., Kawamura H., et al. CT-guided stereotactic surgery for evacuation of hypertensive intracerebral hematoma. Appl Neurophysiol 48 1-6 (1985) 431-439
55. Naff N.J., Hanley D.F., Keyl P.M., et al. Intraventricular thrombolysis speeds blood clot resolution: Results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 54 (2004) 577-583
56. Prasad K., and Shrivastava A. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev (2000) (2):CD000200
57. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 24 (1995) 1581-1587
58. Hacke W., Kaste M., Fieschi C., et al., for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
59. Clarke W.M., Wissman S., Albers G., et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: The ATLANTIS Study: a randomized controlled trial. JAMA 282 (1999) 2019-2026